Off-the-Shelf Stem Cell Therapy Reduces Pain by 58%, Regenerates Cartilage
AI Biotech BioAge Initiates STRIDES Phase 2 Clinical Trial for Obesity Treatment
Lantern Pharma Reports 86% Clinical Benefit in NSCLC Trial, Initial Patient Cohort
Latest